{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:58:37Z","timestamp":1790715517746,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Fragile X syndrome (FXS), the most common inherited cause of intellectual disability, learning disability, and autism spectrum disorder, is associated with an increased prevalence of certain medical conditions including seizures. The goal of this study was to better understand seizures in individuals with FXS using the Fragile X Online Registry with Accessible Research Database, a multisite observational study initiated in 2012 involving FXS clinics in the Fragile X Clinic and Research Consortium. Seizure data were available for 1,607 participants, mostly male (77%) and white (74.5%). The overall prevalence of at least one seizure was 12%, with this rate being significantly higher in males than females (13.7 vs. 6.2%, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). As compared to individuals with FXS without seizures, those with seizures were more likely to have autism spectrum disorder, current sleep apnea, later acquisition of expressive language, more severe intellectual disability, hyperactivity, irritability, and stereotyped movements. The mean age of seizure onset was 6.4 (SD 6.1) years of age with the great majority (&amp;gt;80%) having onset of seizures which was before 10. For those with epilepsy, about half (52%) had seizures for more than 3 years. This group was found to have greater cognitive and language impairment, but not behavioral disruptions, compared with those with seizures for &amp;lt;3 years. Antiepileptic drugs were more often used in males (60.6%) than females (34.8%), and females more often required more than one medication. The most commonly used anticonvulsants were oxcarbazepine, valproic acid, lamotrigine, and levetiracetam. The current study is the largest and first longitudinal study ever conducted to describe seizures in FXS. Overall, this study confirms previous reports of seizures in FXS and extends previous findings by further defining the cognitive and behavioral phenotype of those with epilepsy in FXS. Future studies should further investigate the natural history of seizures in FXS and the characteristics of seizures in FXS in adulthood.<\/jats:p>","DOI":"10.3389\/fped.2021.736255","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:47:12Z","timestamp":1643982432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Seizures in Fragile X Syndrome: Associations and Longitudinal Analysis of a Large Clinic-Based Cohort"],"prefix":"10.3389","volume":"9","author":[{"given":"Elizabeth","family":"Berry-Kravis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn A.","family":"Filipink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailaja","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Hwei","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The FORWARD Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajhg.2009.09.007","article-title":"Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA","volume":"85","author":"Coffee","year":"2009","journal-title":"Am J Hum Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1542\/peds.2013-4301","article-title":"Fragile X syndrome: a review of associated medical problems","volume":"134","author":"Kidd","year":"2014","journal-title":"Pediatrics."},{"key":"B3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng0893-335","article-title":"The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation","volume":"4","author":"Devys","year":"1993","journal-title":"Nat Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1523\/JNEUROSCI.2266-07.2007","article-title":"Mutiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation","volume":"43","author":"Volk","year":"2007","journal-title":"J Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.brainres.2018.04.008","article-title":"Aberrant RNA translation in fragile X syndrome: from FMRP mechanisms to emerging therapeutic strategies","volume":"1693","author":"Banerjee","year":"2018","journal-title":"Brain Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s13311-015-0355-9","article-title":"Therapeutic strategies in fragile X syndrome: from bench to bedside and back","volume":"12","author":"Gross","year":"2015","journal-title":"Neurotherapeutics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroscience.2012.03.049","article-title":"The trouble with spines in fragile X syndrome: density, maturity and plasticity","volume":"251","author":"He","year":"2013","journal-title":"Neuroscience."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1523\/JNEUROSCI.1777-05.2005","article-title":"Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model","volume":"25","author":"Chuang","year":"2005","journal-title":"J Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1157.2000.tb01499.x","article-title":"Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome","volume":"41","author":"Musumeci","year":"2000","journal-title":"Epilepsia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0887-8994(96)00251-2","article-title":"Epilepsy and fragile X gene mutations","volume":"15","author":"Kluger","year":"1996","journal-title":"Pediatr Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ajmg.1320380276","article-title":"Epilepsy and fragile X syndrome: a follow-up study","volume":"38","author":"Musumeci","year":"1991","journal-title":"Am J Med Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1528-1157.1999.tb00824.x","article-title":"Epilepsy and EEG findings in males with fragile X syndrome","volume":"40","author":"Musumeci","year":"1999","journal-title":"Epilepsia."},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/seiz.2000.0492","article-title":"Epilepsy and EEG findings in 18 males with fragile X syndrome","volume":"10","author":"Sabaratnam","year":"2001","journal-title":"Seizure."},{"key":"B15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","article-title":"Epilepsy in fragile X syndrome","volume":"44","author":"Berry-Kravis","year":"2002","journal-title":"Dev Med Child Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ajmg.a.32439","article-title":"Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey","author":"Bailey","year":"2008","journal-title":"Am J Med Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijdevneu.2014.07.002","article-title":"Abnormalities and seizures in genetically diagnosed fragile X syndrome","volume":"38","author":"Heard","year":"2014","journal-title":"Int J Dev Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12888-016-1020-5","article-title":"Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study","volume":"16","author":"Haessler","year":"2016","journal-title":"BMC Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1352\/1944-7558-115.6.461","article-title":"Seizures in fragile X syndrome: characteristics and co-morbid diagnoses","volume":"115","author":"Berry-Kravis","year":"2010","journal-title":"Am J Intellect Dev Disabil."},{"key":"B20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-2008-1071542","article-title":"Benign childhood epilepsy with centrotemporal spikes and the focal sharp wave trait is not linked to the fragile X region","volume":"24","author":"Rees","year":"1993","journal-title":"Neuropediatrics."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/ajmg.a.38373","article-title":"Epilepsy in fragile-X-syndrome mimicking panayiotopoulos syndrome: description of three patients","volume":"173","author":"Bonanni","year":"2017","journal-title":"Am J Med Genet A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1111\/j.1528-1167.2010.02761.x","article-title":"Status epilepticus in fragile X syndrome","volume":"51","author":"Gauthey","year":"2010","journal-title":"Epilepsia."},{"key":"B23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1352\/1944-7558-120.3.230","article-title":"Emergency department and inpatient hospitalizations for young people with fragile X syndrome","volume":"120","author":"McDermott","year":"2015","journal-title":"Am J Intellect Dev Disabil."},{"key":"B24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.braindev.2015.02.009","article-title":"Surgical treatment for medically refractory focal epilepsy in a patient with fragile X syndrome","volume":"37","author":"Kenmuir","year":"2015","journal-title":"Brain Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e20190599","DOI":"10.1542\/peds.2019-0599","article-title":"Fragile females: case series of epilepsy in girls with FMR1 disruption","volume":"144","author":"Myers","year":"2019","journal-title":"Pediatrics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/ajmg.a.32290","article-title":"Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder","author":"Garcia-Nonell","year":"2008","journal-title":"Am J Med Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fnhum.2016.00353","article-title":"Epileptic electroencephalography profile associates with attention problems in children with fragile X syndrome: review and case series","volume":"10","author":"Cowley","year":"2016","journal-title":"Front Hum Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1542\/peds.2016-1159E","article-title":"Fragile X online registry with accessible research database (FORWARD): experience from the fragile X clinical and research consortium to study the natural history fragile X syndrome","volume":"139","author":"Sherman","year":"2017","journal-title":"Pediatrics."},{"key":"B29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1037\/t10453-000","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic."},{"key":"B30","volume-title":"The Social Communication Questionnaire: Manual","author":"Rutter","year":"2003"},{"key":"B31","volume-title":"The Social Responsiveness Scale-Second Edition","author":"Constantino","year":"2012"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10803-011-1370-2","article-title":"Psychometric study of the aberrant behavior checklist in fragile X syndrome and implications for targeted treatment","volume":"42","author":"Sansone","year":"2012","journal-title":"J Autism Dev Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","article-title":"Autism spectrum disorder in fragile X syndrome: characterization using FORWARD","volume":"139","author":"Kaufmann","year":"2017","journal-title":"Pediatrics."},{"key":"B34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.yebeh.2014.12.022","article-title":"Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy","volume":"47","author":"El Achkar","year":"2015","journal-title":"Epilepsy Behav."},{"key":"B35","first-page":"113","article-title":"Prevalence, significance and clinical characteristics of seizures, epilepsy and subclinical electrical activity in autism","volume":"8","author":"Frye","year":"2015","journal-title":"N A J Med Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2346","article-title":"Advances in autism genetics: on the threshold of a new neurobiology","volume":"9","author":"Abrahams","year":"2008","journal-title":"Nat Rev Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.yebeh.2019.07.037","article-title":"The co-occurrence of epilepsy and autism: a systematic review","volume":"98","author":"Lukmanji","year":"2019","journal-title":"Epilepsy Behav"},{"key":"B38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1542\/peds.104.3.405","article-title":"Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders","volume":"104","author":"Lewine","year":"1999","journal-title":"Pediatrics."},{"key":"B39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0387-7604(95)00019-8","article-title":"EEG features and epilepsy in patients with autism","volume":"17","author":"Rossi","year":"1995","journal-title":"Brain Dev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1469-8749.1998.tb15395.x","article-title":"Autism and autistic epileptiform regression with occipital spikes","volume":"40","author":"Nass","year":"1998","journal-title":"Dev Med Child Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.yebeh.2018.09.036","article-title":"Endophenotypes in autism spectrum disorder","volume":"88","author":"Capal","year":"2018","journal-title":"Epilepsy Behav."},{"key":"B42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/0883073809344743","article-title":"Electroencephalogram discharges in atypical cognitive development","volume":"25","author":"Frye","year":"2010","journal-title":"J Child Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.braindev.2010.04.008","article-title":"Autism and epilepsy: historical perspective","volume":"32","author":"Tuchman","year":"2010","journal-title":"Brain Dev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1177\/1362361320942982","article-title":"Epilepsy in adulthood: prevalence, incidence, and associated antiepileptic drug use in autistic adults in a state Medicaid system","volume":"25","author":"Bishop","year":"2021","journal-title":"Autism"},{"key":"B45","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0883073811402203","article-title":"Mortality in individuals with autism, with and without epilepsy","volume":"26","author":"Pickett","year":"2011","journal-title":"J Child Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1192\/bjp.bp.114.160192","article-title":"Premature mortality in autism spectrum disorder","volume":"208","author":"Hirvikoski","year":"2016","journal-title":"Br J Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome","volume":"123","author":"Hagerman","year":"2009","journal-title":"J Pediatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1073\/pnas.1423094112","article-title":"Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures","volume":"112","author":"Myrick","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41431-018-0331-z","article-title":"Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures","volume":"27","author":"Zweier","year":"2019","journal-title":"Eur J Hum Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2013.06.013","article-title":"Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures","volume":"59","author":"Bernard","year":"2013","journal-title":"Neurobiol Dis."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.736255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:47:18Z","timestamp":1643982438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.736255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":51,"alternative-id":["10.3389\/fped.2021.736255"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.736255","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,30]]},"article-number":"736255"}}